TTC is planning a technology opportunities webinar on July 13, 2021 from 11:00 am – noon, EST. Attendees will hear from the NCI’s Dr. Genoveffa Franchini about a new HIV [….]
Leading children’s hospital provides clinical validation, IP for health challenge designed to advance pediatric innovation
NCI Technology Opportunities Webinar: “Complete Tumor Regression Seen in Colon Cancer and Leukemia Animal Models with a Novel High Efficacy Fluorinated Cytidine Therapeutic Compound”
The National Cancer Institute (NCI), Technology Transfer Center (TTC) will host a webinar to highlight a cancer therapeutic technology for collaborative development and/or licensing. The webinar presented by the technology inventor, Dr. Joel Morris, will highlight NCI’s novel, therapeutic fluorinated cytidine compound that shows high efficacy against colon cancer and leukemia. Studies indicated that the therapeutic compound can produce complete regression in xenograph mouse models with minimal effects on body weight. Registration is free.
Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field
Intellectual Property / Tech Law Firm McBee, Moore & Vanik Reaches #13 On Top Patent Firms List In Biotechnology & Organics Field McBee, Moore & Vanik Had 247 Patents Issued [….]